Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x100px
Document › Details

Cellbox Solutions GmbH. (11/1/23). "Press Release: Dr. Hartmut Tintrup Joins Cellbox Solutions GmbH as new CEO". Cologne.

Organisations Organisation Cellbox Solutions GmbH
  Group Cellbox Solutions (Group)
  Organisation 2 Lonza (Group)
Products Product Cellbox transportable CO2 incubator
  Product 2 cell and gene therapy manufacturing (CGT manufacturing)
Persons Person Tintrup, Hartmut (Cellbox Solutions 202311– CEO before Lonza Cologne + Cevec + amaxa US + Exelixis)
  Person 2 Adlkofer, Kathrin (ai:do concepts GmbH 20111– Managing Director before Norgenta 2005–201202 Managing Director)

Seasoned business development professional joins from Lonza

Cellbox Solutions GmbH, a leading provider of live cell logistics solutions for research, development and shipment of cell-based therapies and cellular diagnostics, today announced that Dr. Hartmut Tintrup has joined Cellbox Solutions GmbH as Chief Executive Officer. Hartmut joins the Cellbox team from Lonza, where he served as Global Head Business Development in the Cell & Gene Technologies Business Unit. He brings more than 20 years of international business experience in life science organizations across the U.S. and Europe, including leadership positions at Exelixis, Inc. and CEVEC Pharmaceuticals GmbH. Hartmut received his doctorate degree in Neurochemistry from Goethe University Frankfurt.

“We cordially welcome Hartmut in his new role at Cellbox Solutions and are very excited to have him on board at a pivotal expansion stage into the clinical sector. With more than 22 years of relevant biotech industry experience in senior R&D and commercial functions, he brings a wealth of expertise to our team. I am excited to work closely together with Hartmut,” commented Prof. Kathrin Adlkofer, PhD, Founder of Cellbox Solutions GmbH. “At the same time, I would like to thank our former CEO Wolfgang Kintzel for his vital contributions to advance the Company to its current stage, and my best wishes are with him for his next endeavor.”

“I am very excited to join Cellbox Solutions in this important development phase where Cellbox´ technology is increasingly used by clients to enable and support cell therapy clinical trials. My previous position and experience in the CGT market fits exactly with the needs of Cellbox Solutions in this critical growth phase. I am convinced that Cellbox´ technologies will enable CGT players on the market to bring more therapies to patients,” commented Dr. Hartmut Tintrup.


About Cellbox Solutions GmbH

Founded in 2017, Cellbox Solutions GmbH provides innovative logistics solutions for the global healthcare industry to transport sensitive biological material and therapeutics that suffer from freezing during shipment but require optimal physiological conditions when transported.  The Company´s portable CO2 incubator, Cellbox, provides a controlled and optimal environment for the transport of living cells, organoids, tissues, and other sensitive biological material. Temperature and CO2 levels can be adjusted to ensure optimal incubation conditions. For more information, please visit

Contact Cellbox Solutions GmbH

Prof. Dr. Kathrin Adlkofer
COO and Founder
+49 40 226 316 450

Media Inquiries

Dr. Ludger Wess / Ines-Regina Buth
Managing Partners

Record changed: 2024-01-20


Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x200px

More documents for Cellbox Solutions (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x300px

» top